Melinta Therapeutics Files Chapter 11 Bankruptcy Protection
Have you suffered losses investing in Melinta Therapeutics? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Dispute Resolution claim against the brokerage firm that sold you the investment.
Melinta Therapeutics Inc., a bio-pharmaceutical company specializing in infectious disease treatment, reportedly filed for Chapter 11 bankruptcy in Delaware with plans to continue operating, according to Bloomberg.
Melinta listed as much as $500 million in assets and up to $500 million in liabilities in its bankruptcy petition on Dec 27, 2019.
Melinta’s reported financial challenges were in connection with the business of marketing antibiotics. Many drugmakers are reportedly leaving the industry after the rise of antimicrobial resistance as a leading public health threat.
Recovery of Investment Losses
The problem with biopharmaceutical stocks such as Melinta is that they typically involve a high degree of risk. The research and development process for pharma companies often involves costly and lengthy clinical testing trials that yield specific data. If the expected data or end points are not met, the stock can drop drastically.
Without a strong understanding of the company and its basic operations, investors may be looking at serious losses.
Investigating Potential Claims
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly recommending high-risk biopharma stocks, like Melinta to investors.
Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Firms that fail to do so, may be held responsible for any losses in a FINRA arbitration claim.
If you have concerns regarding investment losses in Melinta, please call the securities attorneys at The White Law Group for a free consultation at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://www.whitesecuritieslaw.com.
Tags: Melinta, Melinta complaints, Melinta default, Melinta help, Melinta high commissions, Melinta information, Melinta investigation, Melinta investment, Melinta investment losses, Melinta investor relations, Melinta investors, Melinta losses, Melinta ppm, Melinta private placement, Melinta prospectus, Melinta recovery options, Melinta risk, Melinta stock information, Melinta update Last modified: January 9, 2020